- Home
- CNTB vs DTF Comparison
CNTB vs DTF Comparison
Compare CNTB & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTB | DTF |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 80.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CNTB | DTF |
|---|---|---|
| Price | $2.67 | $11.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 239.9K | 9.2K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,033,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,706.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $10.95 |
| 52 Week High | $3.82 | $11.60 |
Technical Indicators
Market Signals| Indicator | CNTB | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 45.46 | 53.45 |
| Support Level | $2.16 | $11.20 |
| Resistance Level | $2.78 | $11.47 |
| Average True Range (ATR) | 0.35 | 0.07 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 7.87 | 75.00 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.